TrialLeukemia2004

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).

C-M Wendtner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.